Skip to main content
Neuland Laboratories Limited (NSE:NEULANDLAB)
India flag India · Delayed Price · Currency is INR
16,887
-108 (-0.64%)
At close: Dec 5, 2025

Neuland Laboratories Revenue

Neuland Laboratories had revenue of 5.14B INR in the quarter ending September 30, 2025, with 65.44% growth. This brings the company's revenue in the last twelve months to 15.33B, up 0.34% year-over-year. In the fiscal year ending March 31, 2025, Neuland Laboratories had annual revenue of 14.77B, down -5.24%.

Revenue (ttm)
15.33B
Revenue Growth
+0.34%
P/S Ratio
14.14
Revenue / Employee
8.55M
Employees
1,794
Market Cap
216.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202514.77B-817.43M-5.24%
Mar 31, 202415.59B3.67B30.81%
Mar 31, 202311.91B2.40B25.20%
Mar 31, 20229.52B147.07M1.57%
Mar 31, 20219.37B1.73B22.64%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 549.64B
Divi's Laboratories 100.29B
Cipla 279.66B
Apollo Hospitals Enterprise 232.65B
Zydus Lifesciences 244.94B
Mankind Pharma 135.46B
Aurobindo Pharma 325.14B
Alkem Laboratories 138.90B
Revenue Rankings

Neuland Laboratories News

More News